Single Ventricle Heart Disease clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

    open to eligible people ages 12-18

    This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent who have had the Fontan procedure.

    at UCSF

Our lead scientists for Single Ventricle Heart Disease research studies include .

Last updated: